Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock.

Hongisto M, Kataja A, Tarvasmäki T, Holopainen A, Javanainen T, Jurkko R, Jäntti T, Kimmoun A, Levy B, Mebazaa A, Pulkki K, Sionis A, Tolppanen H, Wollert KC, Harjola VP, Lassus J; CardShock investigators.

J Card Fail. 2019 Nov;25(11):894-901. doi: 10.1016/j.cardfail.2019.07.003. Epub 2019 Jul 13.

PMID:
31310811
2.

Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock.

Jäntti T, Tarvasmäki T, Harjola VP, Parissis J, Pulkki K, Javanainen T, Tolppanen H, Jurkko R, Hongisto M, Kataja A, Sionis A, Silva-Cardoso J, Banaszewski M, Spinar J, Mebazaa A, Lassus J; CardShock investigators.

PLoS One. 2019 May 16;14(5):e0217006. doi: 10.1371/journal.pone.0217006. eCollection 2019.

3.

Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study.

Sionis A, Rivas-Lasarte M, Mebazaa A, Tarvasmäki T, Sans-Roselló J, Tolppanen H, Varpula M, Jurkko R, Banaszewski M, Silva-Cardoso J, Carubelli V, Lindholm MG, Parissis J, Spinar J, Lassus J, Harjola VP, Masip J.

J Intensive Care Med. 2019 Feb 7:885066619828959. doi: 10.1177/0885066619828959. [Epub ahead of print]

PMID:
30732522
4.

Circulating levels of microRNA 423-5p are associated with 90 day mortality in cardiogenic shock.

Jäntti T, Segersvärd H, Tolppanen H, Tarvasmäki T, Lassus J, Devaux Y, Vausort M, Pulkki K, Sionis A, Bayes-Genis A, Tikkanen I, Lakkisto P, Harjola VP.

ESC Heart Fail. 2019 Feb;6(1):98-102. doi: 10.1002/ehf2.12377. Epub 2018 Nov 24.

5.

Predictive value of the baseline electrocardiogram ST-segment pattern in cardiogenic shock: Results from the CardShock Study.

Javanainen T, Tolppanen H, Lassus J, Nieminen MS, Sionis A, Spinar J, Silva-Cardoso J, Greve Lindholm M, Banaszewski M, Harjola VP, Jurkko R.

Ann Noninvasive Electrocardiol. 2018 Sep;23(5):e12561. doi: 10.1111/anec.12561. Epub 2018 May 30.

PMID:
29846022
6.

Prevalence, Temporal Evolution, and Impact on Survival of Ventricular Conduction Blocks in Patients With Acute Coronary Syndrome and Cardiogenic Shock.

Tolppanen H, Javanainen T, Sans-Rosello J, Parenica J, Nieminen T, Pavlusova M, Masip J, Köber L, Banaszewski M, Sionis A, Spinar J, Harjola VP, Jurkko R, Lassus J; CardShock study investigators and for the GREAT Network.

Am J Cardiol. 2018 Jul 15;122(2):199-205. doi: 10.1016/j.amjcard.2018.04.008. Epub 2018 Apr 20.

PMID:
29778237
7.

Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality.

Tarvasmäki T, Haapio M, Mebazaa A, Sionis A, Silva-Cardoso J, Tolppanen H, Lindholm MG, Pulkki K, Parissis J, Harjola VP, Lassus J; CardShock Study Investigators.

Eur J Heart Fail. 2018 Mar;20(3):572-581. doi: 10.1002/ejhf.958. Epub 2017 Sep 27. No abstract available.

8.

Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome.

Tolppanen H, Rivas-Lasarte M, Lassus J, Sadoune M, Gayat E, Pulkki K, Arrigo M, Krastinova E, Sionis A, Parissis J, Spinar J, Januzzi J, Harjola VP, Mebazaa A; CardShock Investigators.

Crit Care Med. 2017 Jul;45(7):e666-e673. doi: 10.1097/CCM.0000000000002336.

PMID:
28403119
9.

Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.

Arrigo M, Truong QA, Szymonifka J, Rivas-Lasarte M, Tolppanen H, Sadoune M, Gayat E, Cohen-Solal A, Ruschitzka F, Januzzi JL Jr, Singh JP, Mebazaa A.

Europace. 2017 Nov 1;19(11):1848-1854. doi: 10.1093/europace/euw305.

10.

Soluble CD146 Is a Novel Marker of Systemic Congestion in Heart Failure Patients: An Experimental Mechanistic and Transcardiac Clinical Study.

Arrigo M, Truong QA, Onat D, Szymonifka J, Gayat E, Tolppanen H, Sadoune M, Demmer RT, Wong KY, Launay JM, Samuel JL, Cohen-Solal A, Januzzi JL Jr, Singh JP, Colombo PC, Mebazaa A.

Clin Chem. 2017 Jan;63(1):386-393. doi: 10.1373/clinchem.2016.260471. Epub 2016 Oct 25.

11.

Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock.

Tolppanen H, Rivas-Lasarte M, Lassus J, Sans-Roselló J, Hartmann O, Lindholm M, Arrigo M, Tarvasmäki T, Köber L, Thiele H, Pulkki K, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, Sionis A, Harjola VP, Mebazaa A.

Ann Intensive Care. 2017 Dec;7(1):6. doi: 10.1186/s13613-016-0229-2. Epub 2017 Jan 4.

12.

Use of noninvasive and invasive mechanical ventilation in cardiogenic shock: A prospective multicenter study.

Hongisto M, Lassus J, Tarvasmaki T, Sionis A, Tolppanen H, Lindholm MG, Banaszewski M, Parissis J, Spinar J, Silva-Cardoso J, Carubelli V, Di Somma S, Masip J, Harjola VP.

Int J Cardiol. 2017 Mar 1;230:191-197. doi: 10.1016/j.ijcard.2016.12.175. Epub 2016 Dec 27.

PMID:
28043661
13.

Effect of precipitating factors of acute heart failure on readmission and long-term mortality.

Arrigo M, Tolppanen H, Sadoune M, Feliot E, Teixeira A, Laribi S, Plaisance P, Nouira S, Yilmaz MB, Gayat E, Mebazaa A; GREAT Network.

ESC Heart Fail. 2016 Jun;3(2):115-121. Epub 2016 Jan 21.

14.

Ventricular conduction abnormalities as predictors of long-term survival in acute de novo and decompensated chronic heart failure.

Tolppanen H, Siirila-Waris K, Harjola VP, Marono D, Parenica J, Kreutzinger P, Nieminen T, Pavlusova M, Tarvasmaki T, Twerenbold R, Tolonen J, Miklik R, Nieminen MS, Spinar J, Mueller C, Lassus J.

ESC Heart Fail. 2016 Mar;3(1):35-43. Epub 2015 Oct 30.

15.

Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy.

Labbene I, Arrigo M, Tavares M, Hajjej Z, Brandão JL, Tolppanen H, Feliot E, Gayat E, Ferjani M, Mebazaa A.

Anaesth Crit Care Pain Med. 2017 Feb;36(1):39-42. doi: 10.1016/j.accpm.2016.02.009. Epub 2016 Jul 17.

PMID:
27436451
16.

Physiological changes in pregnancy.

Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A.

Cardiovasc J Afr. 2016 Mar-Apr;27(2):89-94. doi: 10.5830/CVJA-2016-021. Review.

17.

Management of acute heart failure in elderly patients.

Teixeira A, Arrigo M, Tolppanen H, Gayat E, Laribi S, Metra M, Seronde MF, Cohen-Solal A, Mebazaa A.

Arch Cardiovasc Dis. 2016 Jun-Jul;109(6-7):422-30. doi: 10.1016/j.acvd.2016.02.002. Epub 2016 May 12. Review.

18.

Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of Hemoconcentration.

Ferreira JP, Girerd N, Arrigo M, Medeiros PB, Ricardo MB, Almeida T, Rola A, Tolppanen H, Laribi S, Gayat E, Mebazaa A, Mueller C, Zannad F, Rossignol P, Aragão I.

Medicine (Baltimore). 2016 Apr;95(14):e3307. doi: 10.1097/MD.0000000000003307. Erratum in: Medicine (Baltimore). 2016 Oct 07;95(40):e7325.

19.

Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance.

Mebazaa A, Tolppanen H, Mueller C, Lassus J, DiSomma S, Baksyte G, Cecconi M, Choi DJ, Cohen Solal A, Christ M, Masip J, Arrigo M, Nouira S, Ojji D, Peacock F, Richards M, Sato N, Sliwa K, Spinar J, Thiele H, Yilmaz MB, Januzzi J.

Intensive Care Med. 2016 Feb;42(2):147-63. doi: 10.1007/s00134-015-4041-5. Epub 2015 Sep 14. Review.

PMID:
26370690
20.

Clinical picture and risk prediction of short-term mortality in cardiogenic shock.

Harjola VP, Lassus J, Sionis A, Køber L, Tarvasmäki T, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, Di Somma S, Tolppanen H, Zeymer U, Thiele H, Nieminen MS, Mebazaa A; CardShock Study Investigators; GREAT network.

Eur J Heart Fail. 2015 May;17(5):501-9. doi: 10.1002/ejhf.260. Epub 2015 Mar 28. Erratum in: Eur J Heart Fail. 2015 Sep;17(9):984.

21.

Acute heart failure with and without concomitant acute coronary syndromes: patient characteristics, management, and survival.

Tarvasmäki T, Harjola VP, Nieminen MS, Siirilä-Waris K, Tolonen J, Tolppanen H, Lassus J; FINN-AKVA Study Group.

J Card Fail. 2014 Oct;20(10):723-730. doi: 10.1016/j.cardfail.2014.07.008. Epub 2014 Jul 28.

PMID:
25079300
22.

Causes of death and predictors of 5-year mortality in young adults after first-ever ischemic stroke: the Helsinki Young Stroke Registry.

Putaala J, Curtze S, Hiltunen S, Tolppanen H, Kaste M, Tatlisumak T.

Stroke. 2009 Aug;40(8):2698-703. doi: 10.1161/STROKEAHA.109.554998. Epub 2009 Jul 9.

PMID:
19590052

Supplemental Content

Loading ...
Support Center